Beyond Formulation: Creating Shared Value Through Precision Long-Acting Injectable Technologies

Session details:

1. How Precision Particle Engineering Can Improve LAI Performance

Learn how precision control of particle size and particle characteristics can support reproducibility, scalable manufacturing, and tunable release kinetics across multiple long-acting injectable technologies. Attendees will gain insight into how particle engineering can be used to develop differentiated LAI products.

2. Addressing Patient and Portfolio Challenges Through LAI Innovation

Explore how advanced long-acting injectable technologies can help improve patient experience through enhanced injectability, optimized drug release, and reduced treatment burden, while also creating opportunities for portfolio differentiation, lifecycle management, and adherence improvement.

3. From Platform to Partnership

Discover how pharmaceutical companies and drug delivery innovators can collaborate to transform existing assets into differentiated long-acting products. The session will discuss approaches that create value simultaneously for patients, asset owners, and technology partners through strategic development and partnering models.